featured
Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial
Br J Dermatol 2024 Nov 29;[EPub Ahead of Print], AB Kimball, FG Bechara, A Badat, EJ Giamarellos-Bourboulis, AB Gottlieb, GBE Jemec, Z Reguiai, AP Villani, I Alarcon, A Bansal, F Gasperoni, R Martin, B Paguet, L Uhlmann, H Zouater, S Ravichandran, A AlaviFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.